-
Je něco špatně v tomto záznamu ?
Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6
L. Lacina, J. Brábek, Š. Fingerhutová, J. Zeman, K. Smetana
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- COVID-19 komplikace etiologie patofyziologie MeSH
- cytokiny * MeSH
- dítě MeSH
- interleukin-6 * MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- syndrom systémové zánětlivé reakce etiologie patofyziologie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- předškolní dítě MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
COVID-19 is a transmissible respiratory disease caused by coronavirus SARS-CoV-2, which is similar to SARS or MERS. Its increased severity was noted in aged patients usually over 65 years of age. Children and young people have an asymptomatic or mild course of the disease.Unfortunately, the number of children with problems after mild or asymptomatic COVID-19 recovery is increasing and their troubles resemble Kawasaki disease, although the laboratory findings seem to be different. This condition is called pediatric inflammatory multisystem syndrome (PIMS), and it is a new disease seen in children directly influenced by previous SARS-CoV-2 infection. The literature reports that PIMS typically follows 2-4 weeks after SARS-CoV-2 infection. The clinical symptoms of the affected children are extremely complex, ranging from gastrointestinal to cardiovascular problems with frequent skin and mucosal manifestations, and without intensive treatment they can be fatal. The exact causes of PIMS are recently unknown, however, it is explained as hyperactivation of immunity.In this minireview, we summarize data on the prominent role of the IL-6-IL-6R-STAT3 axis in PIMS aetiopathogenesis. Therapeutic manipulation of IL-6 or IL-6 receptor could be an approach to the treatment of children with severe PIMS.
Charles University 1st Faculty of Medicine BIOCEV Vestec Czech Republic
Charles University 1st Faculty of Medicine Institute of Anatomy Prague Czech Republic
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22000832
- 003
- CZ-PrNML
- 005
- 20220202102629.0
- 007
- ta
- 008
- 220106s2021 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934673 $2 doi
- 035 __
- $a (PubMed)33992044
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Lacina, Lukáš, $d 1979- $7 xx0106429 $u Charles University, First Faculty of Medicine, Institute of Anatomy, Prague, Czech Republic $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Dermatovenerology, Prague, Czech Republic $u Charles University, First Faculty of Medicine, BIOCEV, Vestec, Czech Republic
- 245 10
- $a Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6 / $c L. Lacina, J. Brábek, Š. Fingerhutová, J. Zeman, K. Smetana
- 504 __
- $a Literatura
- 520 9_
- $a COVID-19 is a transmissible respiratory disease caused by coronavirus SARS-CoV-2, which is similar to SARS or MERS. Its increased severity was noted in aged patients usually over 65 years of age. Children and young people have an asymptomatic or mild course of the disease.Unfortunately, the number of children with problems after mild or asymptomatic COVID-19 recovery is increasing and their troubles resemble Kawasaki disease, although the laboratory findings seem to be different. This condition is called pediatric inflammatory multisystem syndrome (PIMS), and it is a new disease seen in children directly influenced by previous SARS-CoV-2 infection. The literature reports that PIMS typically follows 2-4 weeks after SARS-CoV-2 infection. The clinical symptoms of the affected children are extremely complex, ranging from gastrointestinal to cardiovascular problems with frequent skin and mucosal manifestations, and without intensive treatment they can be fatal. The exact causes of PIMS are recently unknown, however, it is explained as hyperactivation of immunity.In this minireview, we summarize data on the prominent role of the IL-6-IL-6R-STAT3 axis in PIMS aetiopathogenesis. Therapeutic manipulation of IL-6 or IL-6 receptor could be an approach to the treatment of children with severe PIMS.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a COVID-19 $x komplikace $x etiologie $x patofyziologie $7 D000086382
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 12
- $a cytokiny $7 D016207
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a interleukin-6 $7 D015850
- 650 _2
- $a syndrom systémové zánětlivé reakce $x etiologie $x patofyziologie $7 D018746
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Brábek, Jan $7 xx0268678 $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Dermatovenerology, Prague, Czech Republic
- 700 1_
- $a Fingerhutová, Šárka $7 xx0268704 $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Pediatrics and Inherited Metabolic Disorders, Prague, Czech Republic
- 700 1_
- $a Zeman, Jiří, $d 1950- $7 skuk0001517 $u Charles University, First Faculty of Medicine and General University Hospital in Prague, Department of Pediatrics and Inherited Metabolic Disorders, Prague, Czech Republic
- 700 1_
- $a Smetana, Karel, $d 1958- $7 jn20000710554 $u Charles University, First Faculty of Medicine, Institute of Anatomy, Prague, Czech Republic $u Charles University, First Faculty of Medicine, BIOCEV, Vestec, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, č. 2 (2021), s. 153-159
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33992044 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20220106 $b ABA008
- 991 __
- $a 20220202102618 $b ABA008
- 999 __
- $a ok $b bmc $g 1755663 $s 1151978
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 70 $c 2 $d 153-159 $e 20210430 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20220106